Personalized Precision Treatment Support

Redefining treatments with AI-driven precision medicine

The M-Platform provides healthcare professionals with precise treatment recommendations. Harnessing AI and comprehensive biomedical data at a molecular level, medical avatars simulate treatments and patient-specific reactions to thousands of medications – matching patients with medicines that work on them. Accessible via local or remote servers, M supports the replication of over 13,500 treated diseases, initially focusing on lymphoma, melanoma, breast- and lung cancer.

m-platform

The M-platform uses pioneering technology to create personalized medical avatarspredicting patient responses to medications with extensive biomedical data. It offers scalable, AI-driven healthcare by modeling over 13,500 diseases, initially focusing on breast, lung, lymphoma, and melanoma cancers

Patient Biomarker Data

Medical Avatar Generation

Tailored Recommendations

Patient Biomarker Data

A medical professional uploads patient biomarker data to the M-platform, which compares it against an extensive genetic, proteomic, and transcriptomic database to create a comprehensive biological profile of the patient.

Medical Avatar Generation

The M-platform generates a medical avatar, a virtual representation that simulates the patient's biological processes and disease progression. It runs simulations on medical avatars with similar symptoms to test various treatment options and identifies the most effective therapies.

Tailored Recommendations

Based on these simulations, the platform provides real-time, personalized drug recommendations tailored to the patient's unique genetic and molecular profile

The M-platform generates a medical avatar, a virtual representation that simulates the patients biological processes and disease progression. It runs simulations on medical avatars with similar symptoms to test various treatment options and identifies the most effective therapies.

Pharma Development Partner

Mimer Platform

The Mimer platform helps pharma companies develop drugs faster and more effectively.